“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart

Article: Clinical and biologic correlates of frailty in older patients with malignant hemopathies

€3.03

SKU: product-article-15202 Category: General

Description
Reviews (0)

Description

Clinical and biologic correlates of frailty in older patients with malignant hemopathies

Reviews

There are no reviews yet.

Be the first to review “Article: Clinical and biologic correlates of frailty in older patients with malignant hemopathies”

You must be logged in to post a review.

Top

Article: Clinical and biologic correlates of frailty in older patients with malignant hemopathies

Description

Reviews

Related products

Article: Highlights in urologic cancer

Article: Highlights in urologic cancer

Article: Highlights in breast cancer

Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma